... Ignacio Melero and Dr. Miguel F. CTEP, Novartis, Numab, Pfizer, Pyramid Bio, Revolution Medicine, SeaGen ... First-in-human trial to evaluate safety, PK/PD and initial clinical activity of NM21-1480, an affinity-balanced PD-L1x4-1BBxHSA trispecific antibody: Results of Phase 1 ...
Inserat ansehen